Medical/Pharmaceuticals
INOVIO and QIAGEN expand collaboration to develop next generation sequencing (NGS) companion diagnostic for INOVIO's VGX-3100 for advanced cervical dysplasia
- Liquid biopsy-based precision test guides patient selection and offers potential for cost-effective, non-invasive alternative to surgical removal of cervical lesions - QIAGEN's bioinformatic expertise raises predictive biomarker power in INOVIO's patient selection - First-in-class next genera...
2021-02-24 14:45
5798
Additional Positive Interim Results from Nanoform's Clinical Study
HELSINKI, Feb. 24, 2021 /PRNewswire/ -- Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, today announced further positive interim results from its ongoing clinical study. The fast absorption data implies that small is powerful® and might offer viable alternatives to com...
2021-02-24 14:33
1206
Antengene Announces NDA for ATG-010 (Selinexor) Granted Priority Review by China's NMPA
SHANGHAI and HONG KONG, Feb. 24, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and onco...
2021-02-24 08:00
2502
US Court Grants MGI's Motion to Amend in Suit Against Illumina
SAN FRANCISCO, Feb. 24, 2021 /PRNewswire/ -- A judge in the U.S. District Court for the Northern District ofCalifornia has granted MGI's motion for leave to amend to add a new inequitable conduct defense of patent infringement lawsuit that Illumina filed against MGI inFebruary 2020 (Case No. 20-c...
2021-02-24 04:00
3395
New Research Highlights the Potential of Transforming Healthcare with Mobile EEG Brain Health Assessments
Recent publications in Frontiers of Neuroscience, Scientific Report and Neurophysiologie Clinique validate the use of Muse® as a mobile EEG device to measure brain health and performance at scale in real-world environments TORONTO, Feb. 24, 2021 /PRNewswire/ -- In a time with overburdened healthc...
2021-02-24 03:21
1453
ScImage Lauded by Frost & Sullivan for Its Cloud-based Enterprise Imaging Platform, PICOM365
Its seamless integration across imaging programs and tools give physicians single-platform access to all the tools needed to view and interpret images and videos from anywhere SANTA CLARA, Calif., Feb. 23, 2021 /PRNewswire/ -- Based on its recent analysis of the North American cloud-based enterp...
2021-02-23 22:00
1460
Rheumatology Clinical Researcher Professor David Hunter Joins George Clinical Scientific Leadership
OVERLAND PARK, Kan., Feb. 23, 2021 /PRNewswire/ -- David Hunter, MBBS, PhD, a renowned clinical researcher and rheumatology expert based inAustralia, has joined the scientific leadership of George Clinical, a global scientifically-backed clinical research organization. Professor Hunter's researc...
2021-02-23 22:00
1270
INOVIO Announces First Subject Dosed in Phase 1B Clinical Trial for its DNA Vaccine Against Lassa Fever, INO-4500, in West Africa
Phase 1B clinical trial is first study for Lassa fever conducted in Africa Goal is for vaccine to be available for emergency use as stockpile product following Phase 2 Progress on INO-4500 reflects INOVIO's focus on and continued commitment to the fight against infectious diseases Trial fully f...
2021-02-23 21:00
4491
RedHill Biopharma Announces Planned Expansion of Opaganib Global Phase 2/3 COVID-19 Study to the U.S.
TEL AVIV, Israel and RALEIGH, NC, Feb. 23, 2021 /PRNewswire/ -- RedHill
Biopharma Ltd.
2021-02-23 20:33
3667
For third year straight, Elekta named one of the world's most ethical companies by Ethisphere
STOCKHOLM, Feb. 23, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has again been recognized as one of theWorld's Most Ethical Companies® by the Ethisphere Institute, a global leader in defining and advancing the standards of ethical business practices. The honor is bestowed upo...
2021-02-23 20:02
3145
Kira Pharmaceuticals Expands Executive Leadership Team with Chief Business Officer, Chief Medical Officer and Chief Commercial Officer, China
CAMBRIDGE, Mass. and SUZHOU, China, Feb. 23, 2021 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, today announced the addition of three seasoned pharmaceutical leaders,Kathy He, R...
2021-02-23 20:00
2636
New Progress in Study on Mechanism of Lianhua Qingwen Capsules for Treatment of COVID-19
SHIJIAZHUANG, China, Feb. 23, 2021 /PRNewswire/ -- Recently, Prof. Caisheng Wu and Prof.Yifeng Chai from the School of Pharmacy, Xiamen University have made new progress in the study of the pharmacologically active ingredients and mechanism of Lianhua Qingwen Capsules, developed and produced by Y...
2021-02-23 17:05
2038
Molecular Stethoscope Announces Publication of its NAFLD/NASH Study in the American Journal of Physiology - Gastrointestinal and Liver Physiology
Circulating cell-free mRNA in blood reflective of NAFLD/NASH liver pathology PALO ALTO, Calif., Feb. 23, 2021 /PRNewswire/ -- Molecular Stethoscope, Inc., a precision medicine biotechnology company, announces publication of its human proof-of-concept study describing the stratification of NAFLD/N...
2021-02-23 16:00
1254
Clover Biopharmaceuticals Raises $230 Million in Oversubscribed Series C Financing
* Series C financing brings total capital raised in the last 12 months to over US$ 400 million (>RMB 2.5 billion) * The proceeds will support the continued development and expansion of Clover's pipeline of protein-based vaccines and biologic cancer therapies CHENGDU, China, Feb. 23, 2021 /PRNe...
2021-02-23 10:59
2302
The BCMA CAR-T Co-developed by Innovent and IASO Was Granted Breakthrough Therapy Designation by the NMPA for the Treatment of Relapsed/Refractory Multiple Myeloma
SAN FRANCISCO and SUZHOU, China, Feb. 23, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-02-23 09:22
5055
AnchorDx Completes USD 40 Million Series C Financing to Advance Cancer Screening and Early Detection Programs
GUANGZHOU, China, Feb. 23, 2021 /PRNewswire/ -- AnchorDx Medical Co., Ltd. ("AnchorDx") announced the completion of aUSD 40 million Series C financing. This round of financing was jointly led by OrbiMed, a world-renowned biomedicine and healthcare venture capital fund, and WuXi Huiying Investment...
2021-02-23 09:02
2234
Octapharma AG: Final data from the NuProtect study published on the immunogenicity of Nuwiq® in previously untreated patients with severe haemophilia A
LACHEN, Switzerland, Feb. 23, 2021 /PRNewswire/ -- Octapharma announced today that the final results from the NuProtect study on the immunogenicity of Nuwiq® in previously untreated patients (PUPs) with severe haemophilia A have been published in the leading medical journalThrombosis and Haemosta...
2021-02-23 00:51
2540
Frost & Sullivan Reveals Regional Trends and Cutting-edge Technologies in the Global MRI Market
Advanced technologies and applications such as point-of-care, pediatrics, dry-magnets, compact MRI and fusion imaging are driving global market SANTA CLARA, Calif., Feb. 23, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis,Technological Advancements and Emerging Applications in the Global ...
2021-02-23 00:48
1133
Dr. Ren Feng Appointed as Chief Scientific Officer of Insilico Medicine
Pharmaceutical veteran joins Insilico Medicine to apply Artificial Intelligence to build a portfolio of Insilico Medicine's proprietary assets and further pipeline development HONG KONG, Feb. 22, 2021 /PRNewswire/ -- Insilico Medicine (the "Company"), a global leader in artificial intelligence f...
2021-02-22 23:28
1621
Los Angeles Lakers Name Hyperice Official Recovery Technology Sponsor
First NBA Team Deal Returns the Recovery Technology Leader to its Southern California Roots EL SEGUNDO, Calif. and IRVINE, Calif., Feb. 22, 2021 /PRNewswire/ -- The Los Angeles Lakers andHyperice announced today a multi-season sponsorship agreement that names Hyperice the Official Recovery Techn...
2021-02-22 22:00
2678
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 292 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 290 media titles]
2024-04-22 06:00
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 287 media titles]
2024-04-18 21:26
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25
Animated Life in Yunnan
[Picked up by 281 media titles]
2024-04-18 14:00
Most Read
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
2024-04-18 21:26
8835
Combining Sustainability and Cybersecurity: Century Iron & Steel and Century Wind Power Both Receive ISO 27001 Information Security Certification
2024-04-19 18:03
8784
Animated Life in Yunnan
2024-04-18 14:00
7822
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
2024-04-19 13:25
7732
IQAX eBL Wins Prestigious APTFF Trade Facilitation Innovation Award 2024
2024-04-18 10:36
3894